Abstract PO3-02-12: Dalpiciclib Combination with Letrozole As Neoadjuvant Therapy for HR-positive HER2-negative Breast Cancer: a Single-Arm, Prospective Exploratory Clinical Study
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined